News

More dermatology patients are taking the popular drugs, but little is known about the biology of “Ozempic face” or how best ...
The rise in GLP-1 use among young women raises concerns about contraceptive efficacy and potential pregnancy risks. Learn ...
On Friday, the company’s health services unit Evernorth unveiled new programs in a reliable growth area: helping payers ...
Keeping up with the GLP-1 area is a full-time job by itself. First off, you have the recent development that these drugs are ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.
Novo Nordisk's collaboration with telehealth providers offers semaglutide at $499/month, enhancing access for self-paying ...
RO is a DTP telehealth company that provides nationwide services. The company offers multiple GLP-1 options and has hired a ...
Yet the disparities by sex, race/ethnicity, and location pale in comparison to a striking overall lack of adoption.
Proportion of adult managed care organizations with availability varied from 24 to 100 percent for SGLT2 inhibitors, 0 to 99 percent for GLP-1 receptor agonists.
Cigna (NYSE:CI) on Friday announced plans to launch a new specialized GLP-1 pharmacy called ENGUIDE from next month, as the ...